FASN and Hyperglycemia: Hepatic FASN deficiency in Mc4r-KO mice suppressed FAO in association with enhancement of hepatic insulin signaling, both of which might suppress gluconeogenesis; these effects were not accompanied by PPARα inhibition or AMPK activation, however, and may have contributed to the amelioration of fed hyperglycemia and improvement of glucose tolerance (Figure 8B).